Statistics Colloquium
October 11 (Fri) 11 a.m.
Alavi Commons Room, 6625 Everett Tower

Use of Statistical Methodology and Computational Tools to Influence the Early Development Plan of a Drug

Kimberly Crimin
Director Statistical Scientist

As decision making within the pharmaceutical industry moves toward being more `information-based', statisticians in the pharmaceutical industry have many opportunities to be active collaborators in all stages of drug development. Some areas in which statisticians can have an impact on the development plan of a drug are: ensuring study designs allow quantification of the desired safety and efficacy of the target product profile, evaluating the operating characteristics of decision rules and study designs under various scenarios and clearly communicating results to non-statisticians.

In this talk I will provide background on a drug development project in asthma, and describe some of the development questions of interest in which quantitative information was provided to the project team to guide the early development plan of the project. I will conclude this talk by describing key attributes a successful statistician in the pharmaceutical industry should possess.

All statistics students are expected to attend.


Past colloquiums


Department of Statistics
3304 Everett Tower
Western Michigan University
Kalamazoo MI 49008-5152 USA
(269) 387-1420 | (269) 387-1419 Fax